ProShares has introduced two new leveraged exchange traded funds tied to the leading index of biotechnology stocks.

The Ultra Nasdaq Biotechnology (BIB) and UltraShort Nasdaq Biotechnology (BIS) seek to provide 200% or -200% of the return of the NASDAQ Biotechnology Index for a single day and carry an expense ratio of 0.95%.

For more ETF investing choices, see the sub-sector ETF directory.